🔹 Adj EPS: $6.81 (Est. $6.73) 🟢
🔹 Revenue: $100.1B (Est. $101.74B) 🔴
🔹 Medical Loss Ratio (MLR): 85.94% (Est. 85.94%) 🟡
🔹 OCR: 13.2% (Improved from 14.7% YoY)
Guidance for 2025:
🔹 Adj EPS: $29.50-$30.00 (Est. $29.84) 🟡
🔹 Revenue: $450B-$455B (Est. $447.66B) 🟢
🔹 Operating Cash Flow: $32B-$33B (Est. $34.04B) 🔴
🔹 Medical Loss Ratio (MLR): 85.69% (Est. 85.69%) 🟡
Cash Flow:
🔹 Full-Year Operating Cash Flow: $24.2B; 1.6x Net Income
Q4 Segment Highlights:
UnitedHealthcare:
🔹 Revenue: $298.2B (Est. $232.95B) 🟢; UP +6% YoY
🔹 Operating Earnings: $15.6B
🔹 Domestic Consumers Served: +2.4M YoY
🔹 Seniors and Complex Needs Offerings: Serving 9.4M; +2.1M YoY
🔹 State-Based Community Offerings: Moderated to 7.4M, reflecting Medicaid redeterminations
Optum:
🔹 Revenue: $253B (Est. $253.0B); UP +12% YoY
🔹 Operating Earnings: $16.7B (Adj: $18.2B) 😕
🔹 Optum Health Revenue: $105.4B; Growth driven by value-based care and expanded services
🔹 Optum Rx Revenue: +15% YoY, adjusted scripts grew to 1.62B
🔹 Optum Insight Revenue: $18.8B (Est. $18.75B) 😑; DOWN -1% YoY due to cyberattack impact of $867M
Operational Metrics:
🔹 Days Claims Payable: 47.0 (vs. 47.9 YoY)
🔹 Return on Equity (Q4): 23.7%
CEO Commentary:
🔸 "UnitedHealth continues to focus on high-quality, affordable health care while simplifying experiences for patients and providers. We’re well-positioned for growth in 2025." – Andrew Witty
Additional Insights:
🔸 UnitedHealth returned over $16B to shareholders through dividends and buybacks in 2024.
🔸 Optum expects to add 650K value-based care patients in 2025.
🔸 Strategic partnerships and state customer expansions provide momentum for 2025 growth.
